Abiopharma

Tross Stuart A 🔴 sold 47.0K shares of MANNKIND CORP (MNKD) at $6.33 Transaction Date: Jan 08, 2026 | Filing ID: 009297

New Form 5 - Innovative Eyewear Inc Filed: 2026-01-09 AccNo: 0001829126-26-000200 Size: 16 KB

Summit Plc - Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 3 - EDAP TMS SA Filed: 2026-01-09 AccNo: 0001829126-26-000199 Size: 11 KB

New Form 3 - EDAP TMS SA Filed: 2026-01-09 AccNo: 0001829126-26-000198 Size: 11 KB

Dambkowski Carl 🟡 adjusted position in 18.7K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $80.06 ($2.1M) Transaction Date: Jan 07, 2026 | Filing ID: 002574

RecycLiCo Grants Stock Options

Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

van der Kamp Hilde Johanna 🟢 acquired 18.7K shares (1 derivative) of NewAmsterdam Pharma Co N.V. (NAMS) at $35.45 Transaction Date: Jan 07, 2026 | Filing ID: 009274

Gulfo Adele M. 🟢 acquired 18.7K shares (1 derivative) of NewAmsterdam Pharma Co N.V. (NAMS) at $35.45 Transaction Date: Jan 07, 2026 | Filing ID: 009273

Davidson Michael H. 🟡 adjusted position in 433.4K shares (1 derivative) of NewAmsterdam Pharma Co N.V. (NAMS) at $35.45 ($12.9M) Transaction Date: Jan 07, 2026 | Filing ID: 009272

Lewis William 🟢 acquired 18.7K shares (1 derivative) of NewAmsterdam Pharma Co N.V. (NAMS) at $35.45 Transaction Date: Jan 07, 2026 | Filing ID: 009271

Smither John W 🟢 acquired 18.7K shares (1 derivative) of NewAmsterdam Pharma Co N.V. (NAMS) at $35.45 Transaction Date: Jan 07, 2026 | Filing ID: 009270

Scott Byron C 🟡 adjusted position in 3.8K shares (1 derivative) of ACCURAY INC (ARAY) at $0.82 Transaction Date: Dec 31, 2025 | Filing ID: 000329